Results from late-breaking clinical trial sessions at the American College of Cardiology 51st Annual Scientific Session.
Indiana University School of Medicine, Krannert Institute of Cardiology, Indianapolis 46202-4800, USA. ewillia@iupui.edu
Eric S
ES
Williams
John M
JM
Miller
D000241:Adenosine / Q000627:therapeutic use; D015906:Angioplasty, Balloon, Coronary; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D017225:Atherectomy, Coronary; D001281:Atrial Fibrillation / Q000401:mortality; D017963:Azithromycin / Q000627:therapeutic use; D023521:Chlamydophila Infections / Q000188:drug therapy; D003327:Coronary Disease / Q000628:therapy*; D017147:Defibrillators, Implantable; D004311:Double-Blind Method; D000077545:Eplerenone; D006333:Heart Failure / Q000628:therapy; D016027:Heart Transplantation; D006353:Heart-Assist Devices; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D017379:Hypertrophy, Left Ventricular / Q000628:therapy; D015425:Myocardial Reperfusion; D011725:Pyridines / Q000627:therapeutic use; D015642:Radiology, Interventional; D013148:Spironolactone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D015607:Stents; D013841:Thiazepines / Q000627:therapeutic use; D015912:Thrombolytic Therapy
D000889:Anti-Arrhythmia Agents; D000959:Antihypertensive Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011725:Pyridines; D013841:Thiazepines; D013148:Spironolactone; C106266:omapatrilat; D000077545:Eplerenone; D017963:Azithromycin; D000241:Adenosine